With the exquisite sensitivity, inherent specificity, and versatility
of polymerase chain reaction (PCR) and other amplification techniques,
it is clear that infectious disease diagnostic tests based on these m
ethods will assume a niche quickly in many clinical microbiology labor
atories. Routine implementation, however, requires that many issues be
addressed, including control of amplicon coni amination, specimen tre
atment to avoid inhibitors, interpretation of positive results when cl
inical significance is unclear, and cost. Laboratory experience with t
he Chlamydia Amplicor product (Roche Molecular Systems, Branchburg, NJ
) is discussed to illustrate these issues. Commercial kit products usi
ng nucleic acid amplification techniques can be introduced into a rout
ine laboratory easily and with a high degree of accuracy.